



Graph awarded €1.1M Deep Tech Grant
GraphTx
Now reading:
Graph awarded €1.1M Deep Tech Grant
Author
GraphTx
Date
Graph has received the Deep Tech Life Science Seed Financing grant from the Austria Wirtschaftsservice (AWS) worth EUR 1.1M.
Directly supported by the Austrian Government to fund life science programs, this program accelerates the development of our AI-driven platform technology and lab-in-the-loop approach in order to discover better data, targets, validation and biomarkers for immune and inflammatory diseases.
Graph’s mission is to develop more effective therapies that target the root causes of immune dysregulation across multiple inflammatory diseases. To enable this work, our team combines AI with sophisticated immunological models and multi-modal data to tackle the unique challenges in this space.
Thank you to the AWS board and program managers for enabling the growth of innovative life science programs and helping the life sciences research ecosystem in Austria further flourish!
Graph has received the Deep Tech Life Science Seed Financing grant from the Austria Wirtschaftsservice (AWS) worth EUR 1.1M.
Directly supported by the Austrian Government to fund life science programs, this program accelerates the development of our AI-driven platform technology and lab-in-the-loop approach in order to discover better data, targets, validation and biomarkers for immune and inflammatory diseases.
Graph’s mission is to develop more effective therapies that target the root causes of immune dysregulation across multiple inflammatory diseases. To enable this work, our team combines AI with sophisticated immunological models and multi-modal data to tackle the unique challenges in this space.
Thank you to the AWS board and program managers for enabling the growth of innovative life science programs and helping the life sciences research ecosystem in Austria further flourish!
Read More
Graph Therapeutics Brings Total Funding to Over $10 Million to Advance Therapeutics Programs in Inflammation and Immunology
Graph Therapeutics Brings Total Funding to Over $10 Million to Advance Therapeutics Programs in Inflammation and Immunology
News
Functional Profiling of Rheumatoid Arthritis Reveals Disease-Specific Immunomodulatory Responses and Novel Therapeutic Targets
Functional Profiling of Rheumatoid Arthritis Reveals Disease-Specific Immunomodulatory Responses and Novel Therapeutic Targets
Research
Functionally-Guided Multiomics Profiling of Human Systemic Inflammation Identifies Myeloid Therapeutic Targets
Functionally-Guided Multiomics Profiling of Human Systemic Inflammation Identifies Myeloid Therapeutic Targets
Research
Graph partners with Parse Biosciences
Graph partners with Parse Biosciences
News
First data in RA - Cytodata 2025
First data in RA - Cytodata 2025
Research
Data Foundations of Precision Immunology
Data Foundations of Precision Immunology
Article
Graph and BIIE announce strategic collaboration to in precision immunology
Graph and BIIE announce strategic collaboration to in precision immunology
News
Graph awarded €1.1M Deep Tech Grant
Graph awarded €1.1M Deep Tech Grant
News
GTX co-founder appointed as Faculty Professor at the BIIE
GTX co-founder appointed as Faculty Professor at the BIIE
News
Graph Awarded €1.1M "Austrian Life Sciences" FFG Grant
Graph Awarded €1.1M "Austrian Life Sciences" FFG Grant
News
Graph Raises $3.1M Pre-Seed Round
Graph Raises $3.1M Pre-Seed Round
News
Copyright GraphTx 2026
Vienna, Asutria
Vienna, Austria
All system opperational